Mineralocorticoid Receptor Antagonists in ESKD

被引：10

作者：

Agarwal, Adhish ^{[1
]}

Cheung, Alfred K. ^{[1
]}

机构：

[1] Univ Utah, Dept Internal Med, Ctr Hlth, Div Nephrol & Hypertens, Salt Lake City, UT 84112 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 07期

关键词：

Humans; mineralocorticoid receptor antagonists; renal dialysis; aldosterone; mineralocorticoids; cardiovascular diseases; risk factors; chronic kidney failure; chronic renal insufficiency; hyperaldosteronism; heart failure; diabetes mellitus; hospitalization; Kidney Failure; Chronic; SPIRONOLACTONE; ALDOSTERONE;

D O I：

10.2215/CJN.13221019

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1047 / 1049

页数：3

共 10 条

[1] The incidence and implications of aldosterone breakthrough [J].

Bomback, Andrew S. ;

Klemmer, Philip J. .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (09) :486-492

[2] Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial [J].

Charytan, David M. ;

Himmelfarb, Jonathan ;

Ikizler, T. Alp ;

Raj, Dominic S. ;

Hsu, Jesse Y. ;

Landis, J. Richard ;

Anderson, Amanda H. ;

Hung, Adriana M. ;

Mehrotra, Rajnish ;

Sharma, Shailendra ;

Weiner, Daniel E. ;

Williams, Mark ;

DiCarli, Marcelo ;

Skali, Hicham ;

Kimmel, Paul L. ;

Kliger, Alan S. ;

Dember, Laura M. ;

Robinson, Emily ;

Aurien-Blajeni, Ezra ;

Cinelli, Maria Angeles ;

Nizam, Tayyaba ;

Rim, Sookyung ;

Seok, Paul ;

Smith, Caroline ;

Rollins, Jasmine ;

Raj, Dominic ;

Regunathan-Shenk, Renu ;

Ramezani, Ali ;

Andrews, Sarah ;

Dumadag, Michelle ;

Franco, Christina ;

Wing, Maria ;

Anderson, Lisa ;

Linke, Lori ;

Manahan, Linda ;

Hung, Adriana ;

Cavanaugh, Kerri ;

Booker, Cindy ;

Brannon, Brigitte ;

Clagett, Adrienne ;

Ellis, Charles ;

Cifelli, Denise ;

Ballard, Shawn ;

Durborow, Marie ;

Howard, Tamara ;

Kuzla, Natalie ;

Nessel, Lisa ;

Tierney, Ann ;

Solomon, Scott ;

Rad, Aria .

KIDNEY INTERNATIONAL, 2019, 95 (04) :973-982

[3] Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients [J].

Drechsler, Christiane ;

Ritz, Eberhard ;

Tomaschitz, Andreas ;

Pilz, Stefan ;

Schoenfeld, Stephan ;

Blouin, Katja ;

Bidlingmaier, Martin ;

Hammer, Fabian ;

Krane, Vera ;

Maerz, Winfried ;

Allolio, Bruno ;

Fassnacht, Martin ;

Wanner, Christoph .

EUROPEAN HEART JOURNAL, 2013, 34 (08) :578-+

[4] A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients [J].

Hammer, Fabian ;

Malzahn, Uwe ;

Donhauser, Julian ;

Betz, Christoph ;

Schneider, Markus P. ;

Grupp, Clemens ;

Pollak, Nils ;

Stoerk, Stefan ;

Wanner, Christoph ;

Krane, Vera ;

Berweck, Susanne ;

Biggar, Patrick ;

Blaser, Christoph ;

Bochannek, Thomas ;

Breunig, Frank ;

Brunner, Michael ;

Bueschges-Seraphin, Beatrix ;

Buettner, Stefan ;

Cakmak, Ahmet ;

Doeltz, Thomas ;

Doerken, Mara ;

Eckardt, Kai-Uwe ;

Fink, Heribert ;

Fischer, Stefan ;

Freisinger, Wolfgang ;

Freiwald, Tilo ;

Gebhardt, Julian ;

Geiger, Helmut ;

Goetz, Ruediger ;

Gossmann, Jan ;

Hammerstingl, Renate ;

Harazny, Joanna ;

Heckel, Michael ;

Heyd-Schramm, Andrea ;

Hoyer, Joachim ;

Janka, Rolf ;

Jung, Oliver ;

Ketteler, Markus ;

Klaeffling, Christina ;

Kleinert, Claudius ;

Kleinert, Marianne ;

Klingbeil, Arnfried ;

Klink, Thorsten ;

Koch, Benjamin-Florian ;

Kosowski, Judith ;

Leidig, Michael ;

Lutz, Jens ;

Marwan, Mohamed ;

Moritz, Maria ;

Moye, Brigitte .

KIDNEY INTERNATIONAL, 2019, 95 (04) :983-991

[5] Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients [J].

Ito, Yasuhiko ;

Mizuno, Masashi ;

Suzuki, Yasuhiro ;

Tamai, Hirofumi ;

Hiramatsu, Takeyuki ;

Ohashi, Hiroshige ;

Ito, Isao ;

Kasuga, Hirotake ;

Horie, Masanobu ;

Maruyama, Shoichi ;

Yuzawa, Yukio ;

Matsubara, Tatsuaki ;

Matsuo, Seiichi .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (05) :1094-1102

[6] Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study [J].

Lin, ChongTing ;

Zhang, Qing ;

Zhang, HuiFang ;

Lin, AiXia .

JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (02) :121-128

[7] Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients [J].

Matsumoto, Yoshihiro ;

Mori, Yasuo ;

Kageyama, Shinji ;

Arihara, Kazuo ;

Sugiyama, Toshikazu ;

Ohmura, Hiromichi ;

Yakushigawa, Toru ;

Sugiyama, Hatsumi ;

Shimada, Yasushi ;

Nojima, Youichi ;

Shio, Nobuo .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) :529-536

[8] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[9] ALDOSTERONE STIMULATES K-SECRETION ACROSS MAMMALIAN COLON INDEPENDENT OF NA ABSORPTION [J].

RECHKEMMER, G ;

HALM, DR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :397-401

[10] Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure [J].

Vardeny, Orly ;

Wu, Dong Hong ;

Desai, Akshay ;

Rossignol, Patrick ;

Zannad, Faiez ;

Pitt, Bertram ;

Solomon, Scott D. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) :2082-2089

← 1 →